Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F
Global Differential Diagnostics Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of various types of diseases such as influenza, COVID diseases, cardiac diseases, and infectious diseases across the globe. Also, the growing accessibility of point-of-care testing products through online platforms will drive the growth of the market in the forecast period. Similarly, growing healthcare decentralization and high investments and funding for project development are expected to enhance the growth of the differential diagnostic market in the coming years. The availability of affordable diagnostic tests for chronic illness in the developing region is anticipated to propel the growth of the market. In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.
Rising the Diagnostic Tests
Due to the growing number of diagnostic tests, people are demanding the best diagnostic test which will easily detect diseases and is anticipated to boost the growth of the market during the forecasted period. Diagnostic tests are performed in a private or public laboratory with appropriate equipment and sometimes expensive instrumentation and staffed with trained and qualified personnel. Growing demand for point-of-care testing which occurs at the nearest site of patient care is sought in the field of infectious bacterial diagnostics to allow the care team to receive more results quickly and make immediate and informed management decisions. For molecular diagnosis, different types of diseases can be detected by using challenging differential diagnosis. Governments and different organizations are investing for research and development purposes in the healthcare sector which is a major factor in driving the growth of the differential diagnostics market during the forecasted period. In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV. Of the total HIV-infected population 45% were women and 2% were below 12. Also, a growing number of clinics will enhance the demand for differential diagnostic tests market over the years. According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO) in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.
Growing Technological Advancements
Growing advancements in diagnostic technology helped physicians to evaluate processes and events in real time. The clinical application of advances in physics and mathematics resulted in the development of diagnostic tools. These developments help physicians to get more accurate, less invasive, and less expensive which will boost the market growth during the forecasted years. Also, the growing demand for diagnostic kits for at-home usage has resulted in technical developments which are expected to create significant growth in the forecast period. Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.
Market Segmentation
Global Differential Diagnostics Market is segmented into treatment type, usability, end use, and by region. Based on treatment type, the market can be segmented into Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, and Sleep Problems. Based on Usability, the market can be segmented into Systems, Kits, Assays, Reagents, and Consumables. Based on end use, the market can be differentiated into Hospitals, Diagnostic Centers, and Others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in the differential diagnostics market. According to CDC in 2020, 79,611,982 people tested for COVID-19 in the United States. This can be ascribed to the increasingly cost-effective covid-19 testing technology in the healthcare sector.
Recent Development
- In January 2021, Roche introduced its Cobas Pulse System in a few nations that accepted the CE Mark. The item is a networked point-of-care solution from Roche Diagnostics' most recent generation. The most recent release provides expert blood glucose management.
- In September 2021, Ortho Clinical Diagnostics announced that Immediate Spin Crossmatch (ISXM), a tool for identifying recipient and donor incompatibility in blood transfusions, will be made available on the company's Ortho Vision and Ortho Vision Max Analyzers.
Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation. are some of the leading players operating in the Global Differential Diagnostics Market.
Report Scope:
In this report, Global Differential Diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Differential Diagnostics Market, By Treatment Type:
- Chest Pain
- Headache
- Fever
- Pneumonia
- Hypertension
- Fatigue
- Sleep Problems
- Differential Diagnostics Market, By Usability:
- Physical Health Disorders
- Mental Health Disorders
- Differential Diagnostics Market, By End Use:
- Hospitals
- Diagnostic Centers
- Others
- Differential Diagnostics Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey
Company Profiles: Detailed analysis of the major companies present in Global Differential Diagnostics Market.
Available Customizations:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
- 2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
- 3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
- 4. Voice of Customer
- 5. Global Differential Diagnostics Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 5.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 5.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
- 5.3. Product Map
- 5.3.1. By Treatment Type
- 5.3.2. By Usability
- 5.3.3. By End Use
- 5.3.4. By Region
- 6. North America Differential Diagnostics Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 6.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 6.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Differential Diagnostics Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Treatment Type
- 6.3.1.2.2. By Usability
- 6.3.1.2.3. By End Use
- 6.3.2. Canada Differential Diagnostics Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Treatment Type
- 6.3.2.2.2. By Usability
- 6.3.2.2.3. By End Use
- 6.3.3. Mexico Differential Diagnostics Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Treatment Type
- 6.3.3.2.2. By Usability
- 6.3.3.2.3. By End Use
- 7. Europe Differential Diagnostics Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 7.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 7.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Differential Diagnostics Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Treatment Type
- 7.3.1.2.2. By Usability
- 7.3.1.2.3. By End Use
- 7.3.2. Germany Differential Diagnostics Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Treatment Type
- 7.3.2.2.2. By Usability
- 7.3.2.2.3. By End Use
- 7.3.3. United Kingdom Differential Diagnostics Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Treatment Type
- 7.3.3.2.2. By Usability
- 7.3.3.2.3. By End Use
- 7.3.4. Italy Differential Diagnostics Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Treatment Type
- 7.3.4.2.2. By Usability
- 7.3.4.2.3. By End Use
- 7.3.5. Spain Differential Diagnostics Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Treatment Type
- 7.3.5.2.2. By Usability
- 7.3.5.2.3. By End Use
- 8. Asia-Pacific Differential Diagnostics Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 8.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 8.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Differential Diagnostics Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Treatment Type
- 8.3.1.2.2. By Usability
- 8.3.1.2.3. By End Use
- 8.3.2. India Differential Diagnostics Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Treatment Type
- 8.3.2.2.2. By Usability
- 8.3.2.2.3. By End Use
- 8.3.3. Japan Differential Diagnostics Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Treatment Type
- 8.3.3.2.2. By Usability
- 8.3.3.2.3. By End Use
- 8.3.4. South Korea Differential Diagnostics Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Treatment Type
- 8.3.4.2.2. By Usability
- 8.3.4.2.3. By End Use
- 8.3.5. Australia Differential Diagnostics Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Treatment Type
- 8.3.5.2.2. By Usability
- 8.3.5.2.3. By End Use
- 9. South America Differential Diagnostics Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 9.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 9.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Differential Diagnostics Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Treatment Type
- 9.3.1.2.2. By Usability
- 9.3.1.2.3. By End Use
- 9.3.2. Argentina Differential Diagnostics Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Treatment Type
- 9.3.2.2.2. By Usability
- 9.3.2.2.3. By End Use
- 9.3.3. Colombia Differential Diagnostics Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Treatment Type
- 9.3.3.2.2. By Usability
- 9.3.3.2.3. By End Use
- 10. Middle East and Africa Differential Diagnostics Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
- 10.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
- 10.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Differential Diagnostics Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Treatment Type
- 10.3.1.2.2. By Usability
- 10.3.1.2.3. By End Use
- 10.3.2. Saudi Arabia Differential Diagnostics Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Treatment Type
- 10.3.2.2.2. By Usability
- 10.3.2.2.3. By End Use
- 10.3.3. UAE Differential Diagnostics Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Treatment Type
- 10.3.3.2.2. By Usability
- 10.3.3.2.3. By End Use
- 11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
- 12. Market Trends & Developments
- 13. Global Differential Diagnostics Market: SWOT Analysis
- 14. Porter’s Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
- 15. Competitive Landscape
- 15.1. Business Overview
- 15.2. Product Offerings
- 15.3. Recent Developments
- 15.4. Financials (As Reported)
- 15.5. Key Personnel
- 15.6. SWOT Analysis
- 15.6.1. Thermo Fisher Scientific Inc.
- 15.6.2. Hologic, Inc.
- 15.6.3. Quidel Corporation.
- 15.6.4. F. Hoffmann-La Roche Ltd.
- 15.6.5. Abbott Laboratories, Inc.
- 15.6.6. Danaher Corporation
- 15.6.7. Meridian Bioscience Inc.
- 15.6.8. GenMark Diagnostics, Inc.
- 15.6.9. Sekisui Diagnostics Co., Ltd.
- 15.6.10. Luminex Corporation.
- 16. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook